| Nov 14 |
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
|
| Nov 12 |
Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
|
| Nov 7 |
Soleno Therapeutics GAAP EPS of -$1.83 misses by $1.22
|
| Nov 6 |
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
|
| Oct 28 |
Soleno Therapeutics to Participate in Upcoming November Investor Conferences
|
| Oct 25 |
Lamb Weston, Adecoagro, and More Stocks See Action From Activist Investors
|
| Oct 21 |
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.
|
| Oct 18 |
TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors
|
| Oct 16 |
Soleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCR
|
| Oct 15 |
Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment
|
